MARK4 anticorps (Internal Region)

N° du produit ABIN784580

L’anticorps Lapin Polyclonal anti-MARK4 a été validé pour IF, IHC (p) et EIA. Il convient pour détecter MARK4 dans des échantillons de Humain et Souris.

Aperçu rapide pour MARK4 anticorps (Internal Region) (ABIN784580)

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MARK4 est non-conjugé

Application: Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Détail du produit anti-MARK4 anticorps

Épitope: Internal Region

Specificité: This antibody detects endogenous levels of total MARK4 protein.

Réactivité croisée (Details): Species reactivity (expected):Mouse.
Species reactivity (tested):Human.

Purification: Immunoaffinity Chromatography

Immunogène: Synthetic peptide Remarks: Antigen Modification: Internal

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS (without Mg2+, Ca2+), pH 7.4, 150 mM Sodium Chloride, 0.02 % Sodium Azide and 50 % Glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the antibody (in aliquots) at -20 °C. Avoid freeze-thaw cycles.

Détails sur MARK4

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Autre désignation: MARK4

Sujet: MARKL1, a MARK type protein kinase, contains a N-terminal serine/threonine kinase domain, a central ubiquitin-associated domain and a C-terminal KA1-associated kinase domain. A smaller mRNA transcript, lacking exon 16 containing the KA1-associated kinase domain, also has been reported.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1

ID gène: 57787

NCBI Accession: NP_001186796